SHAREHOLDER ALERT: Lowey Dannenberg Files Securities Class Action Lawsuit Against Evolus, Inc. (Newport Beach, California) on Behalf of Investors Who Acquired Shares from February 1, 2019 to July 6, 2020, and Encourages Investors to Inquire About the Lead
Retrieved on:
Friday, October 16, 2020
Headquartered in Newport Beach, California, Evolus is a medical aesthetics company that develops, produces, and markets clinical neurotoxins for the treatment of aesthetic concerns.
Key Points:
- Headquartered in Newport Beach, California, Evolus is a medical aesthetics company that develops, produces, and markets clinical neurotoxins for the treatment of aesthetic concerns.
- Evolus sole product is Jeuveau, a purified botulinum toxin used to improve the appearance of moderate to severe frown lines.
- Evolus directly competes with Botox, which is manufactured by Allergan plc and Allergan Inc. (collectively, Allergan) and distributed by Medytox Inc. (Medytox).
- Any member of the proposed Class may move to serve as the Lead Plaintiff through counsel of their choice.